BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 36477475)

  • 1. AAV2/4-RS1 gene therapy in the retinoschisin knockout mouse model of X-linked retinoschisis.
    Scruggs BA; Bhattarai S; Helms M; Cherascu I; Salesevic A; Stalter E; Laird J; Baker SA; Drack AV
    PLoS One; 2022; 17(12):e0276298. PubMed ID: 36477475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The dose-response relationship of subretinal gene therapy with rAAV2tYF-CB-h
    Hassan S; Hsu Y; Thompson JM; Kalmanek E; VandeLune JA; Stanley S; Drack AV
    Front Med (Lausanne); 2024; 11():1304819. PubMed ID: 38414621
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preclinical Dose-Escalation Study of Intravitreal AAV-RS1 Gene Therapy in a Mouse Model of X-linked Retinoschisis: Dose-Dependent Expression and Improved Retinal Structure and Function.
    Bush RA; Zeng Y; Colosi P; Kjellstrom S; Hiriyanna S; Vijayasarathy C; Santos M; Li J; Wu Z; Sieving PA
    Hum Gene Ther; 2016 May; 27(5):376-89. PubMed ID: 27036983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An ex vivo gene therapy approach in X-linked retinoschisis.
    Bashar AE; Metcalfe AL; Viringipurampeer IA; Yanai A; Gregory-Evans CY; Gregory-Evans K
    Mol Vis; 2016; 22():718-33. PubMed ID: 27390514
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal delivery of AAV8 retinoschisin results in cell type-specific gene expression and retinal rescue in the Rs1-KO mouse.
    Park TK; Wu Z; Kjellstrom S; Zeng Y; Bush RA; Sieving PA; Colosi P
    Gene Ther; 2009 Jul; 16(7):916-26. PubMed ID: 19458650
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synaptic pathology in retinoschisis knockout (Rs1-/y) mouse retina and modification by rAAV-Rs1 gene delivery.
    Takada Y; Vijayasarathy C; Zeng Y; Kjellstrom S; Bush RA; Sieving PA
    Invest Ophthalmol Vis Sci; 2008 Aug; 49(8):3677-86. PubMed ID: 18660429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retinoschisin gene therapy and natural history in the Rs1h-KO mouse: long-term rescue from retinal degeneration.
    Kjellstrom S; Bush RA; Zeng Y; Takada Y; Sieving PA
    Invest Ophthalmol Vis Sci; 2007 Aug; 48(8):3837-45. PubMed ID: 17652759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Of men and mice: Human X-linked retinoschisis and fidelity in mouse modeling.
    Vijayasarathy C; Sardar Pasha SPB; Sieving PA
    Prog Retin Eye Res; 2022 Mar; 87():100999. PubMed ID: 34390869
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeted Expression of Retinoschisin by Retinal Bipolar Cells in XLRS Promotes Resolution of Retinoschisis Cysts Sans RS1 From Photoreceptors.
    Vijayasarathy C; Zeng Y; Marangoni D; Dong L; Pan ZH; Simpson EM; Fariss RN; Sieving PA
    Invest Ophthalmol Vis Sci; 2022 Oct; 63(11):8. PubMed ID: 36227606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rearing Light Intensity Affects Inner Retinal Pathology in a Mouse Model of X-Linked Retinoschisis but Does Not Alter Gene Therapy Outcome.
    Marangoni D; Yong Z; Kjellström S; Vijayasarathy C; A Sieving P; Bush RA
    Invest Ophthalmol Vis Sci; 2017 Mar; 58(3):1656-1664. PubMed ID: 28297725
    [TBL] [Abstract][Full Text] [Related]  

  • 11. RS-1 Gene Delivery to an Adult Rs1h Knockout Mouse Model Restores ERG b-Wave with Reversal of the Electronegative Waveform of X-Linked Retinoschisis.
    Zeng Y; Takada Y; Kjellstrom S; Hiriyanna K; Tanikawa A; Wawrousek E; Smaoui N; Caruso R; Bush RA; Sieving PA
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):3279-85. PubMed ID: 15326152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal Structure and Gene Therapy Outcome in Retinoschisin-Deficient Mice Assessed by Spectral-Domain Optical Coherence Tomography.
    Zeng Y; Petralia RS; Vijayasarathy C; Wu Z; Hiriyanna S; Song H; Wang YX; Sieving PA; Bush RA
    Invest Ophthalmol Vis Sci; 2016 Jul; 57(9):OCT277-87. PubMed ID: 27409484
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Road towards Gene Therapy for X-Linked Juvenile Retinoschisis: A Systematic Review of Preclinical Gene Therapy in Cell-Based and Rodent Models of XLRS.
    van der Veen I; Heredero Berzal A; Koster C; Ten Asbroek ALMA; Bergen AA; Boon CJF
    Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38279267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal Injection of an Exosome-Associated Adeno-Associated Viral Vector Enhances Retinoschisin 1 Gene Transduction in the Mouse Retina.
    Wang W; Liu J; Yang M; Qiu R; Li Y; Bian S; Hao B; Lei B
    Hum Gene Ther; 2021 Jul; 32(13-14):707-716. PubMed ID: 33832349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic Rescue of X-Linked Retinoschisis Mouse (
    Vijayasarathy C; Zeng Y; Brooks MJ; Fariss RN; Sieving PA
    Hum Gene Ther; 2021 Jul; 32(13-14):667-681. PubMed ID: 33019822
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Retinal AAV8-RS1 Gene Therapy for X-Linked Retinoschisis: Initial Findings from a Phase I/IIa Trial by Intravitreal Delivery.
    Cukras C; Wiley HE; Jeffrey BG; Sen HN; Turriff A; Zeng Y; Vijayasarathy C; Marangoni D; Ziccardi L; Kjellstrom S; Park TK; Hiriyanna S; Wright JF; Colosi P; Wu Z; Bush RA; Wei LL; Sieving PA
    Mol Ther; 2018 Sep; 26(9):2282-2294. PubMed ID: 30196853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synaptic pathology and therapeutic repair in adult retinoschisis mouse by AAV-RS1 transfer.
    Ou J; Vijayasarathy C; Ziccardi L; Chen S; Zeng Y; Marangoni D; Pope JG; Bush RA; Wu Z; Li W; Sieving PA
    J Clin Invest; 2015 Jul; 125(7):2891-903. PubMed ID: 26098217
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and Biodistribution Evaluation of rAAV2tYF-CB-hRS1, a Recombinant Adeno-Associated Virus Vector Expressing Retinoschisin, in RS1-Deficient Mice.
    Ye GJ; Conlon T; Erger K; Sonnentag P; Sharma AK; Howard K; Knop DR; Chulay JD
    Hum Gene Ther Clin Dev; 2015 Sep; 26(3):177-84. PubMed ID: 26390091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intravitreal Delivery of rAAV2-hSyn-hRS1 Results in Retinal Ganglion Cell-Specific Gene Expression and Retinal Improvement in the
    Zheng Y; Xu X; Fan R; Jiang H; Guo Q; Han X; Liu Y; Luo G
    Hum Gene Ther; 2024 May; 35(9-10):342-354. PubMed ID: 38661546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Solid lipid nanoparticle-based vectors intended for the treatment of X-linked juvenile retinoschisis by gene therapy: In vivo approaches in Rs1h-deficient mouse model.
    Apaolaza PS; Del Pozo-Rodríguez A; Torrecilla J; Rodríguez-Gascón A; Rodríguez JM; Friedrich U; Weber BH; Solinís MA
    J Control Release; 2015 Nov; 217():273-83. PubMed ID: 26400864
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.